Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-23-095021

Director acquired 500 shares (grant or award)

  • Director acquired 321,150 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Pamukcu Rifat · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Owned after D/I
2022-08-23 Conversion : show line 1 in the form +49,280 57,142 D
2023-08-23 Grant or award : show line 2 in the form +500 3,356 D
2022-08-23 Conversion : show line 3 in the form +271,870 14,108 I

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2022-08-23 Conversion : show line 4 in the form Series A Non-Voting Convertible Preferred Stock −4,928 0 D
2022-08-23 Conversion : show line 5 in the form Series A Non-Voting Convertible Preferred Stock −27,187 0 I
2023-08-23 Grant or award : show line 6 in the form Stock Options (Right to Buy) +2,000 2,000 D
Loading xslF345X05/tm2324788-8_4seq1.xml…